L4sBotMBtoTechnology@lemmy.worldEnglish·9 months ago23andMe’s fall from $6 billion to nearly $0 — a valuation collapse of 98% from its peak in 2021(www.wsj.com)external-linkarrow-up1243arrow-down16message-square16file-textfedilink
arrow-up1237arrow-down1external-link23andMe’s fall from $6 billion to nearly $0 — a valuation collapse of 98% from its peak in 2021(www.wsj.com)L4sBotMBtoTechnology@lemmy.worldEnglish·9 months agomessage-square16file-textfedilink
23andMe’s fall from $6 billion to nearly $0 — a valuation collapse of 98% from its peak in 2021::undefined
minus-squareFubarberryEnglisharrow-up52arrow-down0·9 months agolinkfedilinkhttps://archive.is/20240131113900/https://www.wsj.com/health/healthcare/23andme-anne-wojcicki-healthcare-stock-913468f4 Here’s an archived copy of the page.
https://archive.is/20240131113900/https://www.wsj.com/health/healthcare/23andme-anne-wojcicki-healthcare-stock-913468f4
Here’s an archived copy of the page.